胶质母细胞瘤
抗辐射性
癌症研究
胶质瘤
抗辐射性
克隆形成试验
放射治疗
转录组
胶质肉瘤
生物
医学
后天抵抗
细胞培养
佐剂
细胞
渗透(HVAC)
细胞因子
肿瘤微环境
脑瘤
辅助放疗
辐射
肿瘤进展
胶质瘤
辐射耐受性
肿瘤细胞
辐射敏感性
下调和上调
病理
作者
Lingxiang Wu,Lei Cheng,Bin Huang,Runheng Huang,Ravesanker Ezhilarasan,Junxia Zhang,Wei Wu,Guojing Wu,Benqing Yu,Lindsey D. Goodman,Ananya D. Jambhale,Baoli Hu,Apeng Chen,Mengyan Zhu,Min Wu,Peng Xia,Quanzhong Liu,Miao Yu,Zheng Zhao,Zhangchun Cheng
标识
DOI:10.1093/neuonc/noag209
摘要
BACKGROUND: Although radiation therapy (RT) remains one of the most effective treatments for patients with the lethal brain tumor glioblastoma (GBM), quite a number of patients show resistance or relapse shortly after RT. There is an urgent need to uncover the temporal and spatial dynamics of RT resistance during tumor progression and treatment. METHODS: The radio-resistance signature score (RRSS) was calculated by utilizing glioma sphere-forming cells (GSCs) which recapitulate the transcriptomic landscape of GBM. RESULTS: RRSS can assess the RT response on both cell lines and GBM patients. Both transdifferentiated and irradiated glioma cells show increased radiation resistance, demonstrating that the recurrent GBM may acquire resistance along with cell differentiation and selective advantage during treatment. Moreover, RRSS of the marginal tumors is found to be higher than that of core tumors (Wilcoxon's rank-sum test, p-value<0.01). The infiltration of macrophages was significantly associated with radiation resistance (p-value<0.01), which was further validated by single-cell RNAseq based experiments and clonogenic assays. Moreover, we demonstrated that IL1B, a pro-inflammatory cytokine secreted by macrophages, could enhance the radiation resistance of tumor cells. CONCLUSIONS: Our study revealed the spatiotemporal evolution of radiation resistance of GBM, and shed light on the development of novel adjuvant therapeutic strategies.
科研通智能强力驱动
Strongly Powered by AbleSci AI